Fludrocortisone acetate tablets: director disqualification

The CMA has secured the disqualification of a director whose company admitted it breached competition law.

Director disqualification undertakings

1 June 2020: The Competition and Markets Authority (CMA) secured a legally binding disqualification undertaking from Mr Amit Patel, director of Amilco Limited. Mr Patel has given a disqualification undertaking not to act as a director of any UK company for 5 years as of 13 July 2020.

Under the Company Directors Disqualification Act, the CMA has the power to apply to the court to disqualify a director from holding company directorships or performing certain roles in relation to a company for a specified period, if a company which he or she is a director of has breached competition law. The Act also allows the CMA to accept a disqualification undertaking from a director instead of bringing proceedings, which has the same legal effect as a disqualification order.

Further details about the CMA’s investigation can be found on the anti-competitive agreements and conduct in the pharmaceutical sector case page.

Contacts

Director of Litigation

Jessica Radke ([email protected])

CMA press office

[email protected] or call 020 3738 6460

Updates to this page

Published 4 June 2020